Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HSK | Ann: Removal from the Official List - close of trade 21 June 2017 | 21/06/17 | 0 | 777 | |||
|
|||||||
HSK | Ann: Appendix 3Z - McKenna | 01/06/17 | 0 | 474 | |||
|
|||||||
HSK | Ann: Appendix 3Z - Taylor | 01/06/17 | 0 | 505 | |||
|
|||||||
HSK | Ann: Appendix 3Z - Cameron | 01/06/17 | 0 | 439 | |||
|
|||||||
HSK | Ann: Appendix 3X - Anderson | 01/06/17 | 0 | 421 | |||
|
|||||||
HSK | Ann: Appendix 3X - Love | 01/06/17 | 0 | 378 | |||
|
|||||||
HSK | Ann: Appendix 3X - Boland | 01/06/17 | 0 | 331 | |||
|
|||||||
HSK | Ann: Execution of Unsecured Working Capital Facility | 31/05/17 | 0 | 371 | |||
|
See All Discussions